Department of Biological Sciences, University of Delaware, Wolf Hall, Newark, DE 19716, USA.
J Neurooncol. 2011 Oct;105(1):27-44. doi: 10.1007/s11060-011-0557-x. Epub 2011 Mar 4.
The neural adhesion/recognition protein L1 (L1CAM; CD171) has been shown or implicated to function in stimulation of cell motility in several cancer types, including high-grade gliomas. Our previous work demonstrated the expression and function of L1 protein in stimulation of cell motility in rat glioma cells. However, the mechanism of this stimulation is still unclear. This study further investigated the function of L1 and L1 proteolysis in human glioblastoma multiforme (GBM) cell migration and invasion, as well as the mechanism of this stimulation. L1 mRNA was found to be present in human T98G GBM cell line but not in U-118 MG grade III human glioma cell line. L1 protein expression, proteolysis, and release were found in T98G cells and human surgical GBM cells by Western blotting. Exosome-like vesicles released by T98G cells were purified and contained full-length L1. In a scratch assay, T98G cells that migrated into the denuded scratch area exhibited upregulation of ADAM10 protease expression coincident with loss of surface L1. GBM surgical specimen cells exhibited a similar loss of cell surface L1 when xenografted into the chick embryo brain. When lentivirally introduced shRNA was used to attenuate L1 expression, such T98G/shL1 cells exhibited significantly decreased cell motility by time lapse microscopy in our quantitative Super Scratch assay. These cells also showed a decrease in FAK activity and exhibited increased focal complexes. L1 binding integrins which activate FAK were found in T98G and U-118 MG cells. Addition of L1 ectodomain-containing media (1) rescued the decreased cell motility of T98G/shL1 cells and (2) increased cell motility of U-118 MG cells but (3) did not further increase T98G cell motility. Injection of L1-attenuated T98G/shL1 cells into embryonic chick brains resulted in the absence of detectable invasion compared to control cells which invaded brain tissue. These studies support a mechanism where glioma cells at the edge of a cell mass upregulate ADAM10 to proteolyze surface L1 and the resultant ectodomain increases human glioma cell migration and invasion by binding to integrin receptors, activating FAK, and increasing turnover of focal complexes.
神经黏附/识别蛋白 L1(L1CAM;CD171)已被证明或暗示在几种癌症类型中发挥作用,包括高级别神经胶质瘤。我们之前的工作表明 L1 蛋白在刺激大鼠神经胶质瘤细胞运动方面具有表达和功能。然而,这种刺激的机制尚不清楚。本研究进一步探讨了 L1 和 L1 蛋白水解在人多形性胶质母细胞瘤(GBM)细胞迁移和侵袭中的功能,以及这种刺激的机制。在 T98G GBM 细胞系中发现 L1 mRNA 的存在,但在 U-118 MG 级 III 人神经胶质瘤细胞系中不存在。通过 Western blot 发现 T98G 细胞和人手术 GBM 细胞中存在 L1 蛋白表达、蛋白水解和释放。T98G 细胞释放的类外泌体小泡经纯化后含有全长 L1。在划痕实验中,迁移到裸露划痕区域的 T98G 细胞表现出 ADAM10 蛋白酶表达上调,同时表面 L1 丢失。移植到鸡胚脑中的 GBM 手术标本细胞表现出类似的细胞表面 L1 丢失。当使用慢病毒引入 shRNA 来减弱 L1 表达时,通过我们的定量 Super Scratch 实验,T98G/shL1 细胞的运动性明显降低。这些细胞还显示出粘着斑激酶(FAK)活性降低,并表现出增加的焦点复合物。在 T98G 和 U-118 MG 细胞中发现了结合整合素的 L1,整合素激活 FAK。添加含有 L1 细胞外结构域的培养基(1)可挽救 T98G/shL1 细胞运动性降低,(2)增加 U-118 MG 细胞的运动性,但(3)不会进一步增加 T98G 细胞的运动性。与对照细胞相比,将 L1 减弱的 T98G/shL1 细胞注入鸡胚脑内导致无法检测到侵袭,而对照细胞则侵袭脑组织。这些研究支持一种机制,即细胞团边缘的神经胶质瘤细胞上调 ADAM10 以蛋白水解表面 L1,而由此产生的细胞外结构域通过结合整合素受体、激活粘着斑激酶(FAK)并增加焦点复合物的周转率来增加人神经胶质瘤细胞的迁移和侵袭。